View Post

Rapid HIV Testing in Transgender Communities by Community-Based Organizations in Three Cities. Public Health Reports, 123 (Suppl. 3): 101-114.

In by AHFNovember 1, 2008

View Post

Meningitis Due to Hematogenous Dissemination of Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) in a Patient with AIDS. Journal of the International Association of Physicians in AIDS Care, 7(6): 289-291.

In by AHFNovember 1, 2008

View Post

No Residual Activity of Raltegravir After Development of 148 Complex Mutations In Vivo. Journal of the International Association of Physicians in AIDS Care, 7(6): 281-282.

In by AHFNovember 1, 2008

View Post

Service Needs and Factors Related to Quality of Life at Time of Service Enrollment among Persons Living with HIV. Home Health Care Services Quarterly, 18(3): 43-63.

In by AHFOctober 16, 2008

View Post

Maraviroc for Previously Treated Patients with R5 HIV-1 Infection. The New England Journal of Medicine, 359: 1429-1441.

In by AHFOctober 1, 2008

View Post

Raltegravir: The First in a New Class of Integrase Inhibitors for the Treatment of HIV. Expert Review of Anti-Infective Therapy, 6(4): 419-426.

In by AHFAugust 16, 2008

View Post

Hepatitis C Patients’ Self-Reported Adherence to Treatment with Pegylated Interferon and Ribavirin. Alimentary Pharmacology and Therapeutics, 28: 289-293.

In by AHFJuly 1, 2008

View Post

False-Positivity of HIV-2 Immunoblots in a Cohort of Elite Suppressors Infected with HIV-1. Journal of Acquired Immune Deficiency Syndromes, 47(5): 644.

In by AHFApril 1, 2008

View Post

Darunavir: A New HIV-1 Protease Inhibitor for the Treatment of HIV Infection. Future HIV Therapy, 2(2): 125-136.

In by AHFMarch 16, 2008

View Post

Efficacy and Safety of Once-Daily Darunavir/Ritonavir Versus Lopinavir/Ritonavir in Treatment-Naive HIV-1-Infected Patients at Week 48. AIDS, 22(12): 1389-1397.

In by AHFMarch 1, 2008